|Articles|September 1, 2003
Phase IV filgrastim study shows drug lives up to expectations
Amgen's filgrastim delivers what it promises in a phase IV study
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape
3
CagriSema Demonstrates Superior Hemoglobin and Weight Loss Results in Type 2 Diabetes
4
How New Federal Spending Bill Bolsters CMS Oversight, PBM Transparency
5



















